Barclays’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-900,000
Closed -$5.26M 5398
2024
Q3
$5.26M Buy
+900,000
New +$4.44M ﹤0.01% 2055
2023
Q2
Sell
-118,500
Closed -$974K 4885
2023
Q1
$974K Buy
+118,500
New +$1.31M ﹤0.01% 2746

Other funds holding MPT

Barclays's MPT Position: Q2 2026 in Review

Barclays reduced its Medical Properties Trust (MPT) stake by 3% in Q2 2026, selling an estimated $35.9K and leaving 234,598 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2745.

Barclays first reported a position in MPT in Q2 2013 and has held it in 53 quarters since. The position peaked at $50M in Q1 2022. 489 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Barclays held 234,598 shares of Medical Properties Trust worth $1.08M as of Q2 2026.
  • Barclays sold 7,246 Medical Properties Trust shares in Q2 2026, an estimated $35.9K.
  • Medical Properties Trust made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2745 holding.
  • Barclays first reported a position in Medical Properties Trust in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Medical Properties Trust position peaked at $50M in Q1 2022.
  • 489 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.